GT199900061A - Formulaciones farmaceuticas. - Google Patents

Formulaciones farmaceuticas.

Info

Publication number
GT199900061A
GT199900061A GT199900061A GT199900061A GT199900061A GT 199900061 A GT199900061 A GT 199900061A GT 199900061 A GT199900061 A GT 199900061A GT 199900061 A GT199900061 A GT 199900061A GT 199900061 A GT199900061 A GT 199900061A
Authority
GT
Guatemala
Prior art keywords
pharmaceutical formulations
sildenafil
dosage forms
free base
oral dosage
Prior art date
Application number
GT199900061A
Other languages
English (en)
Inventor
Cristi Bell-Huff
Thomas Francis Dolan
Angela Carol Gatlin Hausberger
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of GT199900061A publication Critical patent/GT199900061A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Abstract

ESTA INVENCION SE REFIERE A NUEVAS FORMULACIONES FARMACEUTICAS DEL COMPUESTO SILDENAFILO Y EN PARTICULAR A FORMAS DE DOSIFICACION ORAL DE DESINTEGRACION RAPIDA QUE CONTIENEN SILDENAFILO EN FORMA DE SU BASE LIBRE.
GT199900061A 1998-05-15 1999-04-23 Formulaciones farmaceuticas. GT199900061A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8564698P 1998-05-15 1998-05-15

Publications (1)

Publication Number Publication Date
GT199900061A true GT199900061A (es) 2000-10-14

Family

ID=22193027

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199900061A GT199900061A (es) 1998-05-15 1999-04-23 Formulaciones farmaceuticas.

Country Status (32)

Country Link
US (1) US20020002172A1 (es)
EP (1) EP0960621A3 (es)
JP (1) JPH11349483A (es)
KR (1) KR19990088249A (es)
CN (1) CN1251758A (es)
AP (1) AP9901534A0 (es)
AR (1) AR016481A1 (es)
AU (1) AU753478B2 (es)
BG (1) BG103396A (es)
BR (1) BR9902086A (es)
CA (1) CA2272042A1 (es)
CO (1) CO5060503A1 (es)
DZ (1) DZ2786A1 (es)
EA (1) EA002830B1 (es)
GT (1) GT199900061A (es)
HN (1) HN1999000066A (es)
HR (1) HRP990144A2 (es)
HU (1) HUP9901606A2 (es)
ID (1) ID23299A (es)
IS (1) IS5046A (es)
MA (1) MA26629A1 (es)
NO (1) NO992339L (es)
NZ (1) NZ335772A (es)
OA (1) OA11040A (es)
PA (1) PA8472901A1 (es)
PE (1) PE20000546A1 (es)
PL (1) PL333118A1 (es)
SG (1) SG79255A1 (es)
SK (1) SK61599A3 (es)
TR (1) TR199901077A3 (es)
YU (1) YU21999A (es)
ZA (1) ZA993338B (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000020033A1 (fr) * 1998-10-05 2000-04-13 Eisai Co., Ltd. Comprimes se delitant immediatement dans la cavite buccale
AU3724400A (en) * 1999-03-08 2000-09-28 Merck & Co., Inc. Methods and compositions for treating erectile dysfunction
EP1171134A4 (en) * 1999-03-16 2005-01-05 Pentech Pharmaceuticals Inc CONTROLLED DELIVERY OF SILDENAFIL ADMINISTERED BY SUBLINGUAL OR ORAL
WO2000057857A1 (en) * 1999-03-25 2000-10-05 Yuhan Corporation Rapidly disintegrable tablet for oral administration
KR100344198B1 (ko) * 1999-10-08 2002-07-19 일양약품주식회사 실데나필 시트레이트의 속효제형
NZ524572A (en) 2000-09-06 2004-08-27 Tanabe Seiyaku Co Oral compositions comprising phosphodiesterase inhibitors ( PDE inhibitor )and an acidic substance such as fumaric acid with improved drug efficacy due to decrease solubility in neutral and alkaline regions
US6733781B2 (en) * 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
IN192750B (es) * 2000-12-15 2004-05-15 Ranbaxy Lab Ltd
US6544552B2 (en) * 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
EP1226818A1 (en) * 2001-01-26 2002-07-31 Pfizer Products Inc. Pharmaceutical dosage forms with enhanced cohesive and compressibility properties
WO2002089808A1 (de) * 2001-05-09 2002-11-14 Bayer Healthcare Ag Neue verwendung von 2-phenyl-substituierten imidazotriazinonen
LV12978B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
KR20040037138A (ko) * 2001-09-28 2004-05-04 가부시키가이샤산와카가쿠켄큐쇼 유핵형 속용붕괴성 성형품
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
DE10232113A1 (de) * 2002-07-16 2004-01-29 Bayer Ag Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel
SE0202365D0 (sv) * 2002-08-05 2002-08-05 Pharmacia Ab New formulation and use thereof
WO2004073729A1 (ja) * 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
USRE45404E1 (en) 2003-03-27 2015-03-03 Shin Nippon Biomedical Laboratories, Ltd. Powder medicine applicator for nasal cavity
US20050042177A1 (en) * 2003-07-23 2005-02-24 Elan Pharma International Ltd. Novel compositions of sildenafil free base
US7670624B2 (en) 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
DE102004023069A1 (de) * 2004-05-11 2005-12-08 Bayer Healthcare Ag Neue Darreichungsformen des PDE 5-Inhibitors Vardenafil
JP4922762B2 (ja) * 2004-08-10 2012-04-25 株式会社新日本科学 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
DE102005001989A1 (de) * 2005-01-15 2006-07-20 Bayer Healthcare Ag Intravenöse Formulierungen von PDE-Inhibitoren
DE102005009240A1 (de) 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften
DE102005009241A1 (de) * 2005-03-01 2006-09-07 Bayer Healthcare Ag Arzneiformen mit kontrollierter Bioverfügbarkeit
US20070031349A1 (en) * 2005-06-23 2007-02-08 David Monteith Rapidly absorbing oral formulations of PDE 5 inhibitors
AU2006299232A1 (en) * 2005-09-29 2007-04-12 Bayer Schering Pharma Aktiengesellschaft PDE inhibitors and combinations thereof for the treatment of urological disorders
US8337817B2 (en) 2006-12-26 2012-12-25 Shin Nippon Biomedical Laboratories, Ltd. Preparation for transnasal application
NZ579170A (en) * 2007-02-12 2012-05-25 Dmi Biosciences Inc Reducing side effects of tramadol
US20100184769A1 (en) * 2007-06-13 2010-07-22 Bayer Schering Pharma Aktiengesellschaft Pde inhibitors for the treatment of hearing impairment
FR2932682B1 (fr) * 2008-06-23 2013-07-12 Bionetwork Nouvelles formes pharmaceutiques a effet rapide et les utilisations des compositions pharmaceutiques ainsi obtenus.
EP2405905B1 (en) * 2009-03-09 2016-06-29 SPI Pharma, INC. Highly compactable and durable direct compression excipients and excipient systems
DE102009016584A1 (de) 2009-04-06 2010-10-07 Ratiopharm Gmbh Schmelztablette, enthaltend ein Sildenafil-Salz
WO2010131486A1 (en) * 2009-05-15 2010-11-18 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
WO2011013003A2 (en) * 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
WO2011030351A2 (en) 2009-09-03 2011-03-17 Rubicon Research Private Limited Taste - masked pharmaceutical compositions
EP2338474A1 (de) 2009-12-23 2011-06-29 Ratiopharm GmbH Oral dispersible Tablette enthaltend kompaktierte Sildenafil-Base
DE102010024866A1 (de) * 2010-06-24 2011-12-29 Pharmatech Gmbh Formulierung zur Geschmacksmaskierung
AU2012214939B2 (en) * 2011-02-11 2016-11-17 Ctc Bio, Inc. Sildenafil-free base-containing film preparation and method for producing same
KR101418406B1 (ko) * 2011-08-24 2014-07-10 한미약품 주식회사 실데나필 유리 염기를 포함하는 구강 붕해정
MX366768B (es) * 2011-12-08 2019-07-17 Laboratorios Liomont S A De C V Tableta orodispersable de sildenafil y metodo para preparar la misma.
KR102239291B1 (ko) 2013-06-28 2021-04-14 한미약품 주식회사 타다라필 또는 이의 약학적으로 허용가능한 염을 포함하는 저작정 제제
CN105769887B (zh) * 2014-12-23 2019-04-30 上海复星星泰医药科技有限公司 一种复方果糖二磷酸钠果糖口崩片及其制备方法
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
CN114246835A (zh) * 2022-01-05 2022-03-29 河北龙海药业有限公司 一种枸橼酸西地那非口腔崩解片的制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
US5624677A (en) * 1995-06-13 1997-04-29 Pentech Pharmaceuticals, Inc. Controlled release of drugs delivered by sublingual or buccal administration
DE19532142A1 (de) * 1995-08-31 1997-03-06 Siemens Ag Verfahren und Vorrichtung zur Regelung eines vierdimensionalen Vektors einer Strecke mittels eines wertediskreten Stellgliedes mit begrenzter Schaltfrequenz
GB9523752D0 (en) * 1995-11-21 1996-01-24 Pfizer Ltd Pharmaceutical formulations
CN1309561A (zh) * 1997-05-29 2001-08-22 持田制药株式会社 勃起机能障碍治疗剂
TW542719B (en) * 1998-02-23 2003-07-21 Pfizer Res & Dev Method of treating impotence due to spinal cord injury
US6124461A (en) * 1998-05-26 2000-09-26 Saint Louis University, Health Services Center, Research Administration Compounds, compositions, and methods for treating erectile dysfunction
EP1171134A4 (en) * 1999-03-16 2005-01-05 Pentech Pharmaceuticals Inc CONTROLLED DELIVERY OF SILDENAFIL ADMINISTERED BY SUBLINGUAL OR ORAL

Also Published As

Publication number Publication date
ID23299A (id) 2000-04-05
KR19990088249A (ko) 1999-12-27
MA26629A1 (fr) 2004-12-20
SG79255A1 (en) 2001-03-20
AU2812699A (en) 1999-11-25
JPH11349483A (ja) 1999-12-21
AR016481A1 (es) 2001-07-04
BG103396A (bg) 2000-01-31
TR199901077A2 (en) 1999-12-21
AU753478B2 (en) 2002-10-17
CN1251758A (zh) 2000-05-03
BR9902086A (pt) 2000-05-02
HN1999000066A (es) 1999-09-29
DZ2786A1 (fr) 2003-12-01
NZ335772A (en) 2000-12-22
TR199901077A3 (tr) 1999-12-21
AP9901534A0 (en) 1999-06-30
EP0960621A2 (en) 1999-12-01
NO992339L (no) 1999-11-16
HUP9901606A2 (en) 2002-09-28
EA002830B1 (ru) 2002-10-31
EP0960621A3 (en) 2000-01-05
EA199900373A3 (ru) 2000-08-28
OA11040A (en) 2003-01-01
PE20000546A1 (es) 2000-07-07
CO5060503A1 (es) 2001-07-30
EA199900373A2 (ru) 1999-12-29
NO992339D0 (no) 1999-05-14
IS5046A (is) 1999-11-16
PA8472901A1 (es) 2000-09-29
ZA993338B (en) 2000-11-14
HU9901606D0 (en) 1999-07-28
HRP990144A2 (en) 2000-02-29
SK61599A3 (en) 2000-12-11
US20020002172A1 (en) 2002-01-03
PL333118A1 (en) 1999-11-22
CA2272042A1 (en) 1999-11-15
YU21999A (sh) 2002-03-18

Similar Documents

Publication Publication Date Title
GT199900061A (es) Formulaciones farmaceuticas.
ID27504A (id) Formulasi oral baru
HN1998000115A (es) Formas de dosificación farmacéuticas sólidas
HN2001000244A (es) Inhibidores de espiropirimidin - 2, 4, 6 - triona metaloproteinasas.
ES2539945T3 (es) Formulaciones orales de agonistas opioides resistentes a manipulaciones indebidas
ECSP055726A (es) Composición farmacéutica estabilizada que contiene excipientes básicos
ITMI20011337A0 (it) Composizioni farmaceutiche orali a rilascio modificato del principio attivo
HN1997000151A (es) Forma de dosificacion farmaceutica que enmascara el sabor y que se libera rapidamente.
NO20011217D0 (no) Doseringsform omfattende væskeformulering
ATE301999T1 (de) Racecadotril enthaltende trockene pulverformulierung
CR8003A (es) Composiciones limpiadoras en la forma de una tableta
HN2001000262A (es) Kit de repinotano
ES2170143T3 (es) Composiciones que comprenden halofantrina en una forma especial.
ITMI20011338A0 (it) Composizioni farmaceutiche orali a rilascio immediato del principio attivo
HN2003000115A (es) Formulacion farmaceutica que comprende melatonina
ATE297760T1 (de) Pharmazeutische zusammensetzungen enthaltend terbinafin
HN2001000137A (es) Procedimiento para la fabricacion de una forma farmaceutica semi solida conteniendo dexketoprofeno trometamol y su utilizacion en el tratamiento topico de la inflamacion
GT199800090A (es) Formas de dosificacion de solucion encapsulada de sertralina.
GT200400183A (es) Formas de dosificacion de azitromicina con efectos secundarios reducidos
PA8644501A1 (es) Composicion farmaceutica
PA8558501A1 (es) 1,3-diarilprop-2-en1-onas, composiciones que las contienen y su utilizacion
ES2182931T3 (es) Composiciones farmaceuticas para uso topico sobre la base de ketoprofeno.
UY27170A1 (es) Formulación de medicamento que contiene un agente agonista muscarínico
GEP20074101B (en) Novel association of an antithrombotic agent with aspirin and use thereof for treating atherothrombotic diseases
IT1318654B1 (it) Composizioni farmaceutiche comprendenti agenti antiinfiammatori e lorousi.